NovoCure Debt to Equity Ratio 2014-2024 | NVCR

Current and historical debt to equity ratio values for NovoCure (NVCR) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. NovoCure debt/equity for the three months ending March 31, 2024 was 1.59.
NovoCure Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2024-03-31 $0.76B $0.36B 2.12
2023-12-31 $0.78B $0.36B 2.16
2023-09-30 $0.75B $0.39B 1.91
2023-06-30 $0.74B $0.42B 1.79
2023-03-31 $0.74B $0.43B 1.72
2022-12-31 $0.75B $0.44B 1.70
2022-09-30 $0.73B $0.45B 1.64
2022-06-30 $0.72B $0.44B 1.63
2022-03-31 $0.71B $0.44B 1.64
2021-12-31 $0.73B $0.41B 1.78
2021-09-30 $0.71B $0.41B 1.71
2021-06-30 $0.70B $0.40B 1.76
2021-03-31 $0.70B $0.37B 1.87
2020-12-31 $0.58B $0.48B 1.21
2020-09-30 $0.12B $0.31B 0.40
2020-06-30 $0.26B $0.27B 0.98
2020-03-31 $0.26B $0.24B 1.08
2019-12-31 $0.26B $0.22B 1.20
2019-09-30 $0.25B $0.19B 1.33
2019-06-30 $0.25B $0.16B 1.56
2019-03-31 $0.24B $0.13B 1.93
2018-12-31 $0.23B $0.11B 2.03
2018-09-30 $0.20B $0.12B 1.75
2018-06-30 $0.20B $0.11B 1.77
2018-03-31 $0.20B $0.11B 1.86
2017-12-31 $0.15B $0.11B 1.34
2017-09-30 $0.15B $0.12B 1.25
2017-06-30 $0.14B $0.12B 1.19
2017-03-31 $0.14B $0.13B 1.05
2016-12-31 $0.14B $0.14B 0.98
2016-09-30 $0.13B $0.16B 0.84
2016-06-30 $0.06B $0.19B 0.34
2016-03-31 $0.06B $0.22B 0.27
2015-12-31 $0.06B $0.25B 0.23
2015-09-30 $0.05B $0.12B 0.43
2015-06-30 $0.05B $0.14B 0.34
2015-03-31 $0.00B $0.00B 0.00
2014-12-31 $0.00B 0.00
2014-09-30 $0.00B $0.00B 0.00
2013-12-31 $0.02B $0.17B 0.10
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $2.032B $0.509B
NovoCure Limited is an oncology company. The Company is engaged in developing a therapy called Tumor Treating Fields for the treatment of solid tumor cancers. It operates primarily in the United States, Germany, Switzerland and Japan. NovoCure Limited is based in Saint Helier, Channel Islands.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $180.226B 18.03
Vertex Pharmaceuticals (VRTX) United States $127.971B 32.93
Regeneron Pharmaceuticals (REGN) United States $117.870B 28.83
CSL (CSLLY) Australia $99.637B 0.00
Gilead Sciences (GILD) United States $90.212B 17.97
Bristol Myers Squibb (BMY) United States $86.496B 40.64
GSK (GSK) United Kingdom $81.637B 9.75
Moderna (MRNA) United States $46.947B 0.00
Biogen (BIIB) United States $32.997B 15.11
Alnylam Pharmaceuticals (ALNY) United States $29.800B 0.00
Argenex SE (ARGX) Netherlands $27.398B 0.00
BioNTech SE (BNTX) Germany $20.463B 172.16
Illumina (ILMN) United States $18.735B 133.65
Genmab (GMAB) Denmark $18.386B 21.55
BioMarin Pharmaceutical (BMRN) United States $16.199B 63.19
BeiGene (BGNE) Cayman Islands $15.604B 0.00
Incyte (INCY) United States $14.638B 22.64
Sarepta Therapeutics (SRPT) United States $13.834B 1219.58
Bio-Techne Corp (TECH) United States $12.255B 46.29
Insmed (INSM) United States $11.336B 0.00
Legend Biotech (LEGN) United States $10.742B 0.00
QIAGEN (QGEN) Netherlands $9.662B 20.64
Vaxcyte (PCVX) United States $9.144B 0.00
Exact Sciences (EXAS) United States $8.888B 0.00
Bio-Rad Laboratories (BIO.B) United States $8.393B 27.45
Roivant Sciences (ROIV) United Kingdom $8.222B 0.00
Intra-Cellular Therapies (ITCI) United States $8.074B 0.00
Ascendis Pharma (ASND) Denmark $7.938B 0.00
Blueprint Medicines (BPMC) United States $7.314B 0.00
Repligen (RGEN) United States $7.240B 94.58
Halozyme Therapeutics (HALO) United States $6.916B 19.20
Exelixis (EXEL) United States $6.852B 35.31
Zealand Pharma (ZLDPF) Denmark $6.537B 0.00
Cytokinetics (CYTK) United States $6.021B 0.00
Krystal Biotech (KRYS) United States $5.907B 0.00
Viking Therapeutics (VKTX) United States $5.702B 0.00
Nuvalent (NUVL) United States $5.238B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $4.776B 0.00
Apellis Pharmaceuticals (APLS) United States $4.497B 0.00
Avidity Biosciences (RNA) United States $4.428B 0.00
Alkermes (ALKS) Ireland $4.197B 16.42
Immunovant (IMVT) United States $4.093B 0.00
Axsome Therapeutics (AXSM) United States $4.087B 0.00
ImmunityBio (IBRX) United States $3.949B 0.00
Guardant Health (GH) United States $3.916B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.696B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $3.524B 0.00
Arcellx (ACLX) United States $3.369B 0.00
Denali Therapeutics (DNLI) United States $3.356B 0.00
Merus (MRUS) Netherlands $3.274B 0.00
Twist Bioscience (TWST) United States $3.273B 0.00
Xenon Pharmaceuticals (XENE) Canada $3.254B 0.00
IDEAYA Biosciences (IDYA) United States $3.235B 0.00
Biohaven (BHVN) United States $3.218B 0.00
ADMA Biologics Inc (ADMA) United States $3.187B 125.00
Amicus Therapeutics (FOLD) United States $3.045B 0.00
Rhythm Pharmaceuticals (RYTM) United States $3.035B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.995B 0.00
Apogee Therapeutics (APGE) United States $2.934B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $2.856B 0.00
Morphic Holding (MORF) United States $2.835B 0.00
MorphoSys AG (MOR) Germany $2.808B 0.00
Geron (GERN) United States $2.776B 0.00
SpringWorks Therapeutics (SWTX) United States $2.729B 0.00
Certara (CERT) United States $2.667B 61.41
Kymera Therapeutics (KYMR) United States $2.606B 0.00
Myriad Genetics (MYGN) United States $2.512B 0.00
Vericel (VCEL) United States $2.507B 0.00
Janux Therapeutics (JANX) United States $2.474B 0.00
Intellia Therapeutics (NTLA) United States $2.444B 0.00
Fortrea Holdings (FTRE) United States $2.397B 29.46
Celldex Therapeutics (CLDX) United States $2.395B 0.00
Iovance Biotherapeutics (IOVA) United States $2.331B 0.00
CG Oncology (CGON) United States $2.321B 0.00
Beam Therapeutics (BEAM) United States $2.227B 0.00
Rocket Pharmaceuticals (RCKT) United States $2.186B 0.00
Bavarian Nordic (BVNRY) Denmark $2.142B 9.33
Protagonist Therapeutics (PTGX) United States $2.117B 14.80
Novavax (NVAX) United States $2.098B 0.00
Edgewise Therapeutics (EWTX) United States $2.051B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.988B 0.00
Arvinas (ARVN) United States $1.985B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.964B 0.00
Zai Lab (ZLAB) China $1.962B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.900B 14.48
Akero Therapeutics (AKRO) United States $1.895B 0.00
NeoGenomics (NEO) United States $1.890B 0.00
Vera Therapeutics (VERA) United States $1.865B 0.00
Mirum Pharmaceuticals (MIRM) United States $1.863B 0.00
Neumora Therapeutics (NMRA) United States $1.852B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $1.849B 0.00
Ligand Pharmaceuticals (LGND) United States $1.826B 29.84
Galapagos (GLPG) Belgium $1.794B 0.00
Keros Therapeutics (KROS) United States $1.753B 0.00
Structure Therapeutics (GPCR) United States $1.706B 0.00
Kura Oncology (KURA) United States $1.581B 0.00
MannKind (MNKD) United States $1.563B 191.33
Kiniksa Pharmaceuticals (KNSA) Bermuda $1.517B 0.00
Belite Bio (BLTE) United States $1.488B 0.00
Longboard Pharmaceuticals (LBPH) United States $1.430B 0.00
Dynavax Technologies (DVAX) United States $1.429B 182.00
Nurix Therapeutics (NRIX) United States $1.424B 0.00
Vir Biotechnology (VIR) United States $1.381B 0.00
Sana Biotechnology (SANA) United States $1.353B 0.00
Arcus Biosciences (RCUS) United States $1.316B 0.00
Prothena (PRTA) Ireland $1.311B 0.00
Gyre Therapeutics (GYRE) United States $1.306B 0.00
ANI Pharmaceuticals (ANIP) United States $1.302B 16.16
Day One Biopharmaceuticals (DAWN) United States $1.299B 0.00
Spyre Therapeutics (SYRE) United States $1.240B 0.00
Autolus Therapeutics (AUTL) United Kingdom $1.144B 0.00
Arcutis Biotherapeutics (ARQT) United States $1.140B 0.00
Disc Medicine (IRON) United States $1.136B 0.00
Cullinan Therapeutics (CGEM) United States $1.101B 0.00
MiMedx (MDXG) United States $1.092B 46.25
Tyra Biosciences (TYRA) United States $1.092B 0.00
Tango Therapeutics (TNGX) United States $1.057B 0.00
Immatics (IMTX) Germany $1.046B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.025B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $1.022B 0.00
Humacyte (HUMA) United States $0.994B 0.00
Praxis Precision Medicines (PRAX) United States $0.977B 0.00
AnaptysBio (ANAB) United States $0.976B 0.00
Viridian Therapeutics (VRDN) United States $0.956B 0.00
AbCellera Biologics (ABCL) Canada $0.885B 0.00
Liquidia Technologies (LQDA) United States $0.868B 0.00
Mesoblast (MESO) Australia $0.862B 0.00
CureVac (CVAC) Germany $0.849B 0.00
Olema Pharmaceuticals (OLMA) United States $0.847B 0.00
Cytek Biosciences (CTKB) United States $0.838B 0.00
Cogent Biosciences (COGT) United States $0.831B 0.00
Immunome (IMNM) United States $0.825B 0.00
Dianthus Therapeutics (DNTH) United States $0.821B 0.00
89BIO (ETNB) United States $0.818B 0.00
Stoke Therapeutics (STOK) United States $0.790B 0.00
CARGO Therapeutics (CRGX) United States $0.774B 0.00
Nuvation Bio (NUVB) United States $0.774B 0.00
Abivax SA (ABVX) France $0.763B 0.00
WAVE Life Sciences (WVE) Singapore $0.756B 0.00
Pliant Therapeutics (PLRX) United States $0.756B 0.00
Tectonic Therapeutic (TECX) United States $0.747B 0.00
Scholar Rock Holding (SRRK) United States $0.735B 0.00
Travere Therapeutics (TVTX) United States $0.735B 0.00
Zymeworks (ZYME) United States $0.725B 0.00
Rapport Therapeutics (RAPP) $0.724B 0.00
Oric Pharmaceuticals (ORIC) United States $0.721B 0.00
Arbutus Biopharma (ABUS) United States $0.719B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.695B 0.00
Mineralys Therapeutics (MLYS) United States $0.679B 0.00
ACELYRIN, INC (SLRN) United States $0.674B 0.00
Replimune (REPL) United States $0.672B 0.00
ArriVent BioPharma (AVBP) United States $0.653B 0.00
Prime Medicine (PRME) United States $0.651B 0.00
Astria Therapeutics (ATXS) United States $0.646B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.643B 0.00
Celcuity (CELC) United States $0.641B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.633B 0.00
REGENXBIO (RGNX) United States $0.629B 0.00
GH Research (GHRS) Ireland $0.622B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.619B 0.00
Alector (ALEC) United States $0.614B 0.00
Adaptive Biotechnologies (ADPT) United States $0.613B 0.00
Avid Bioservices (CDMO) United States $0.610B 0.00
IGM Biosciences (IGMS) United States $0.609B 0.00
Alumis (ALMS) United States $0.606B 0.00
Allogene Therapeutics (ALLO) United States $0.604B 0.00
Emergent Biosolutions (EBS) United States $0.601B 0.00
ITeos Therapeutics (ITOS) United States $0.596B 0.00
Pharming Group (PHAR) Netherlands $0.587B 0.00
Applied Therapeutics (APLT) United States $0.582B 0.00
Entrada Therapeutics (TRDA) United States $0.578B 27.16
Neurogene (NGNE) United States $0.562B 0.00
MEREO BIOPHARMA (MREO) United Kingdom $0.558B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.557B 0.00
Pharming Group (PHGUF) Netherlands $0.553B 0.00
Terns Pharmaceuticals (TERN) United States $0.552B 0.00
PepGen (PEPG) United States $0.551B 0.00
Contineum Therapeutics (CTNM) United States $0.550B 0.00
Castle Biosciences (CSTL) United States $0.549B 0.00
Erasca (ERAS) United States $0.544B 0.00
Annexon (ANNX) United States $0.538B 0.00
Fulcrum Therapeutics (FULC) United States $0.535B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.534B 0.00
PureTech Health (PRTC) United States $0.524B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.520B 0.00
Fate Therapeutics (FATE) United States $0.519B 0.00
GRAIL (GRAL) United States $0.501B 0.00
Anavex Life Sciences (AVXL) United States $0.500B 0.00
Third Harmonic Bio (THRD) United States $0.495B 0.00
Voyager Therapeutics (VYGR) United States $0.477B 0.00
Northwest Biotherapeutics (NWBO) United States $0.474B 0.00
Oculis Holding AG (OCS) Switzerland $0.473B 0.00
MaxCyte (MXCT) United States $0.473B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.465B 0.00
Absci (ABSI) United States $0.464B 0.00
Aura Biosciences (AURA) United States $0.453B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.431B 0.00
Editas Medicine (EDIT) United States $0.428B 0.00
C4 Therapeutics (CCCC) United States $0.424B 0.00
Ocugen (OCGN) United States $0.422B 0.00
Revance Therapeutics (RVNC) United States $0.419B 0.00
Kyverna Therapeutics (KYTX) United States $0.419B 0.00
Anika Therapeutics (ANIK) United States $0.408B 349.62
Precigen (PGEN) United States $0.405B 0.00
Alto Neuroscience (ANRO) United States $0.400B 0.00
EnGene Holdings (ENGN) United States $0.389B 0.00
Urogen Pharma (URGN) United States $0.380B 0.00
UniQure (QURE) Netherlands $0.370B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.369B 0.00
TScan Therapeutics (TCRX) United States $0.364B 0.00
AC Immune (ACIU) Switzerland $0.360B 0.00
ALX Oncology Holdings (ALXO) United States $0.351B 0.00
Q32 Bio (QTTB) United States $0.349B 0.00
Cabaletta Bio (CABA) United States $0.347B 0.00
Inozyme Pharma (INZY) United States $0.343B 0.00
Nautilus Biotechnology (NAUT) United States $0.338B 0.00
Kamada (KMDA) Israel $0.338B 25.57
Solid Biosciences (SLDB) United States $0.335B 0.00
XOMA Royalty (XOMA) United States $0.333B 0.00
Sutro Biopharma (STRO) United States $0.326B 0.00
Amarin (AMRN) Ireland $0.324B 0.00
Nkarta (NKTX) United States $0.320B 0.00
Jasper Therapeutics (JSPR) United States $0.319B 0.00
Atea Pharmaceuticals (AVIR) United States $0.318B 0.00
Scilex Holding (SCLX) United States $0.316B 0.00
Poseida Therapeutics (PSTX) United States $0.313B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.301B 0.00
Cartesian Therapeutics (RNAC) United States $0.300B 0.00
MeiraGTx Holdings (MGTX) United States $0.299B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.299B 0.00
Alimera Sciences (ALIM) United States $0.292B 0.00
Tenaya Therapeutics (TNYA) United States $0.288B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.286B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.285B 0.00
Inovio Pharmaceuticals (INO) United States $0.274B 0.00
CorMedix Inc (CRMD) United States $0.261B 0.00
Codexis (CDXS) United States $0.260B 0.00
Mersana Therapeutics (MRSN) United States $0.245B 0.00
Gossamer Bio (GOSS) United States $0.240B 0.00
Molecular Partners AG (MOLN) Switzerland $0.237B 0.00
2seventy Bio (TSVT) United States $0.234B 0.00
Design Therapeutics (DSGN) United States $0.229B 0.00
Zura Bio (ZURA) United States $0.228B 0.00
Prima BioMed (IMMP) Australia $0.226B 0.00
ChromaDex (CDXC) United States $0.224B 0.00
23andMe Holding (ME) United States $0.224B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.221B 0.00
GENFIT S.A (GNFT) France $0.218B 0.00
Shattuck Labs (STTK) United States $0.214B 0.00
Caribou Biosciences (CRBU) United States $0.210B 0.00
Abeona Therapeutics (ABEO) United States $0.205B 0.00
Greenwich LifeSciences (GLSI) United States $0.201B 0.00
Trevi Therapeutics (TRVI) United States $0.198B 0.00
Ventyx Biosciences (VTYX) United States $0.197B 0.00
Biomea Fusion (BMEA) United States $0.196B 0.00
Inhibrx Biosciences (INBX) $0.195B 0.00
Coherus BioSciences (CHRS) United States $0.195B 0.00
Generation Bio (GBIO) United States $0.195B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.194B 0.00
G1 Therapeutics (GTHX) United States $0.192B 0.00
Oncobiologics (OTLK) United States $0.190B 0.00
Renovaro (RENB) United States $0.190B 0.00
XBiotech (XBIT) United States $0.189B 0.00
Rezolute (RZLT) United States $0.187B 0.00
Seres Therapeutics (MCRB) United States $0.186B 0.00
Puma Biotechnology (PBYI) United States $0.180B 11.30
Adherex Technologies (FENC) United States $0.180B 219.00
Candel Therapeutics (CADL) United States $0.179B 0.00
Adocia (ADOCY) France $0.178B 0.00
Innate Pharma S.A (IPHA) France $0.175B 0.00
FibroBiologics (FBLG) United States $0.174B 0.00
Skye Bioscience (SKYE) United States $0.171B 0.00
INmune Bio (INMB) United States $0.169B 0.00
ScPharmaceuticals (SCPH) United States $0.168B 0.00
Repare Therapeutics (RPTX) Canada $0.165B 0.00
Lifecore Biomedical (LFCR) United States $0.164B 0.00
Adverum Biotechnologies (ADVM) United States $0.161B 0.00
Syros Pharmaceuticals (SYRS) United States $0.161B 0.00
Rani Therapeutics Holdings (RANI) United States $0.158B 0.00
Compugen (CGEN) Israel $0.158B 0.00
Kodiak Sciences (KOD) United States $0.157B 0.00
DiaMedica Therapeutics (DMAC) United States $0.149B 0.00
Elevation Oncology (ELEV) United States $0.148B 0.00
Vigil Neuroscience (VIGL) United States $0.147B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.146B 0.00
Invivyd (IVVD) United States $0.146B 0.00
Agenus (AGEN) United States $0.144B 0.00
PDS Biotechnology (PDSB) United States $0.143B 0.00
Compass Therapeutics (CMPX) United States $0.138B 0.00
Inventiva S.A (IVA) France $0.137B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.135B 0.00
Adlai Nortye (ANL) Cayman Islands $0.134B 0.00
X4 Pharmaceuticals (XFOR) United States $0.134B 0.00
BioStem Technologies (BSEM) $0.133B 0.00
Immunic (IMUX) United States $0.132B 0.00
Semper Paratus Acquisition (TVGN) United States $0.129B 0.00
ATyr Pharma (ATYR) United States $0.128B 0.00
Bluebird Bio (BLUE) United States $0.125B 0.00
Athira Pharma (ATHA) United States $0.124B 0.00
Nuvectis Pharma (NVCT) United States $0.124B 0.00
Opthea (OPT) Australia $0.122B 0.00
Annovis Bio (ANVS) United States $0.120B 0.00
Werewolf Therapeutics (HOWL) United States $0.119B 0.00
Seer (SEER) United States $0.119B 0.00
Akoya Biosciences (AKYA) United States $0.117B 0.00
Cellectis S.A (CLLS) France $0.116B 0.00
Adagene (ADAG) China $0.116B 0.00
I-Mab (IMAB) China $0.115B 0.00
CytomX Therapeutics (CTMX) United States $0.113B 7.25
Adicet Bio (ACET) United States $0.113B 0.00
TELA Bio (TELA) United States $0.112B 0.00
Rapt Therapeutics (RAPT) United States $0.109B 0.00
Coya Therapeutics (COYA) United States $0.109B 0.00
VistaGen Therapeutics (VTGN) United States $0.106B 0.00
Cardiff Oncology (CRDF) United States $0.105B 0.00
Omega Therapeutics (OMGA) United States $0.102B 0.00
IO Biotech (IOBT) Denmark $0.101B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.100B 0.00
BioHarvest Sciences (CNVCF) Canada $0.098B 0.00
CervoMed (CRVO) United States $0.095B 0.00
HilleVax (HLVX) United States $0.094B 0.00
Sagimet Biosciences (SGMT) United States $0.094B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.093B 0.00
Alpha Teknova (TKNO) United States $0.093B 0.00
Elutia (ELUT) United States $0.091B 0.00
Eton Pharmaceuticals (ETON) United States $0.090B 87.75
InflaRx (IFRX) Germany $0.090B 0.00
DBV Technologies S.A (DBVT) France $0.089B 0.00
Checkpoint Therapeutics (CKPT) United States $0.089B 0.00
AN2 Therapeutics (ANTX) United States $0.087B 0.00
Verastem (VSTM) United States $0.087B 0.00
Clearside Biomedical (CLSD) United States $0.084B 0.00
Benitec Biopharma (BNTC) United States $0.084B 0.00
BioAtla (BCAB) United States $0.084B 0.00
Instil Bio (TIL) United States $0.083B 0.00
Sangamo Therapeutics (SGMO) United States $0.082B 0.00
Chimerix (CMRX) United States $0.082B 0.00
BeyondSpring (BYSI) United States $0.081B 0.00
Genenta Science S.p.A (GNTA) Italy $0.081B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.081B 0.00
Ikena Oncology (IKNA) United States $0.081B 0.00
LENZ Therapeutics (LENZ) United States $0.080B 0.00
Boundless Bio (BOLD) United States $0.079B 0.00
Affimed (AFMD) Germany $0.079B 0.00
Oncolytics Biotech (ONCY) Canada $0.078B 0.00
Cognition Therapeutics (CGTX) United States $0.075B 0.00
Spero Therapeutics (SPRO) United States $0.075B 2.74
Genelux (GNLX) United States $0.075B 0.00
Kronos Bio (KRON) United States $0.075B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.074B 0.00
Ovid Therapeutics (OVID) United States $0.073B 0.00
Gritstone Bio (GRTS) United States $0.073B 0.00
Theratechnologies (THTX) Canada $0.072B 0.00
Connect Biopharma Holdings (CNTB) United States $0.071B 0.00
Earth Science Tech (ETST) United States $0.070B 0.00
VTv Therapeutics (VTVT) United States $0.069B 0.00
Precision BioSciences (DTIL) United States $0.069B 0.00
Galena Biopharma (SLS) United States $0.069B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.068B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.068B 0.00
Allakos (ALLK) United States $0.067B 0.00
Intensity Therapeutics (INTS) United States $0.067B 0.00
MediciNova (MNOV) United States $0.066B 0.00
Eyenovia (EYEN) United States $0.065B 0.00
HOOKIPA Pharma (HOOK) United States $0.064B 0.00
Vor Biopharma (VOR) $0.063B 0.00
Entera Bio (ENTX) Israel $0.063B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.062B 0.00
Enzo Biochem (ENZ) United States $0.060B 0.00
Aileron Therapeutics (ALRN) United States $0.060B 0.00
Immix Biopharma (IMMX) United States $0.058B 0.00
Turnstone Biologics (TSBX) United States $0.057B 0.00
Celularity (CELU) United States $0.057B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.056B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.055B 0.00
Rallybio (RLYB) United States $0.055B 0.00
Leap Therapeutics (LPTX) United States $0.054B 0.00
Estrella Immunopharma (ESLA) United States $0.054B 0.00
Cidara Therapeutics (CDTX) United States $0.054B 0.00
Passage Bio (PASG) United States $0.054B 0.00
Aerovate Therapeutics (AVTE) United States $0.053B 0.00
Ocuphire Pharma (OCUP) United States $0.051B 0.00
Lantern Pharma (LTRN) United States $0.050B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.049B 0.00
Atara Biotherapeutics (ATRA) United States $0.049B 0.00
OKYO Pharma (OKYO) $0.048B 0.00
Fortress Biotech (FBIO) United States $0.048B 0.00
Elicio Therapeutics (ELTX) United States $0.048B 0.00
ARCA Biopharma (ABIO) United States $0.047B 0.00
Kezar Life Sciences (KZR) United States $0.046B 0.00
LakeShore Biopharma (LSB) China $0.046B 0.00
NextCure (NXTC) United States $0.046B 0.00
Lexaria Bioscience (LEXX) Canada $0.046B 0.00
BioXcel Therapeutics (BTAI) United States $0.045B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.044B 0.00
Aligos Therapeutics (ALGS) United States $0.044B 0.00
CalciMedica (CALC) United States $0.043B 0.00
Dyadic (DYAI) United States $0.042B 0.00
Bionano Genomics (BNGO) United States $0.042B 0.00
Ocean Biomedical (OCEA) United States $0.040B 0.00
IN8bio (INAB) United States $0.039B 0.00
Cue Biopharma (CUE) United States $0.037B 0.00
Aadi Bioscience (AADI) United States $0.037B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.037B 0.00
Promis Neurosciences (PMN) Canada $0.037B 0.00
Xilio Therapeutics (XLO) United States $0.037B 0.00
Curis (CRIS) United States $0.036B 0.00
Immuneering (IMRX) United States $0.036B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.034B 0.00
Cyclo Therapeutics (CYTH) United States $0.033B 0.00
NKGen Biotech (NKGN) United States $0.033B 0.00
Quince Therapeutics (QNCX) United States $0.033B 0.00
MiNK Therapeutics (INKT) United States $0.031B 0.00
Dare Bioscience (DARE) United States $0.031B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.031B 0.00
Equillium (EQ) United States $0.030B 0.00
Pluri (PLUR) Israel $0.030B 0.00
BioAffinity Technologies (BIAF) United States $0.029B 0.00
Lisata Therapeutics (LSTA) United States $0.029B 0.00
Clene (CLNN) United States $0.029B 0.00
RenovoRx (RNXT) United States $0.028B 0.00
Bolt Biotherapeutics (BOLT) United States $0.028B 0.00
SAB Biotherapeutics (SABS) United States $0.026B 0.00
Evogene (EVGN) Israel $0.026B 0.00
Beyond Air (XAIR) United States $0.025B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.025B 0.00
Biora Therapeutics (BIOR) United States $0.025B 0.00
Femasys (FEMY) United States $0.025B 0.00
UNITY Biotechnology (UBX) United States $0.025B 0.00
Cocrystal Pharma (COCP) United States $0.024B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.024B 0.00
Orgenesis (ORGS) United States $0.023B 0.00
HCW Biologics (HCWB) United States $0.023B 0.00
Carmell (CTCX) United States $0.022B 0.00
Forte Biosciences (FBRX) United States $0.022B 0.00
Aprea Therapeutics (APRE) United States $0.022B 0.00
Spruce Biosciences (SPRB) United States $0.022B 0.00
NeuroBo Pharmaceuticals (NRBO) United States $0.021B 0.00
Cara Therapeutics (CARA) United States $0.020B 0.00
Longeveron (LGVN) United States $0.020B 0.00
Vincerx Pharma (VINC) United States $0.019B 0.00
KALA BIO (KALA) United States $0.019B 0.00
Synlogic (SYBX) United States $0.019B 0.00
Apollomics (APLM) United States $0.018B 0.00
VBI Vaccines (VBIV) United States $0.018B 0.00
Sensei Biotherapeutics (SNSE) United States $0.017B 0.00
Aytu BioPharma (AYTU) United States $0.016B 0.00
Talis Biomedical (TLIS) United States $0.016B 0.00
Evaxion Biotech (EVAX) Denmark $0.015B 0.00
Edesa Biotech (EDSA) Canada $0.015B 0.00
Galecto (GLTO) Denmark $0.014B 0.00
IMMURON (IMRN) Australia $0.014B 0.00
Kintara Therapeutics (KTRA) United States $0.013B 0.00
Imunon (IMNN) United States $0.013B 0.00
Chemomab Therapeutics (CMMB) Israel $0.013B 0.00
BRIACELL THERAP (BCTX) Canada $0.013B 0.00
Vaccinex (VCNX) United States $0.012B 0.00
Lumos Pharma (LUMO) United States $0.012B 0.00
Biorestorative Therapies (BRTX) United States $0.012B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.011B 0.00
Aptose Biosciences (APTO) Canada $0.011B 0.00
Monopar Therapeutics (MNPR) United States $0.011B 0.00
Senti Biosciences (SNTI) United States $0.011B 0.00
Eterna Therapeutics (ERNA) United States $0.011B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.011B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.010B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.010B 0.00
AEterna Zentaris (AEZS) Canada $0.010B 0.00
Moleculin Biotech (MBRX) United States $0.009B 0.00
ABVC BioPharma (ABVC) United States $0.009B 0.00
Cyclerion Therapeutics (CYCN) United States $0.009B 0.00
Purple Biotech (PPBT) Israel $0.009B 0.00
Silo Pharma (SILO) United States $0.009B 0.00
Elevai Labs (ELAB) United States $0.009B 0.00
Kineta (KA) United States $0.009B 0.00
Organovo Holdings (ONVO) United States $0.008B 0.00
NuCana (NCNA) United Kingdom $0.008B 0.00
Prana Biotechnology (ATHE) Australia $0.008B 0.00
Novogen (KZIA) Australia $0.008B 0.00
ANEW Medical (WENA) United States $0.007B 0.00
Pulmatrix (PULM) United States $0.007B 0.00
Sunshine Biopharma (SBFM) United States $0.007B 0.00
Cadrenal Therapeutics (CVKD) United States $0.007B 0.00
Telesis Bio (TBIO) United States $0.007B 0.00
TC BioPharm (Holdings) (TCBP) United Kingdom $0.007B 0.00
Bionomics (BNOX) Australia $0.007B 0.00
Tenax Therapeutics (TENX) United States $0.007B 0.00
GeoVax Labs (GOVX) United States $0.006B 0.00
Notable Labs (NTBL) United States $0.006B 0.00
AquaBounty Technologies (AQB) United States $0.006B 0.00
Pasithea Therapeutics (KTTA) United States $0.006B 0.00
TFF Pharmaceuticals (TFFP) United States $0.006B 0.00
Titan Pharmaceuticals (TTNP) United States $0.005B 0.00
Synaptogenix (SNPX) United States $0.005B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.005B 0.00
Biofrontera (BFRI) United States $0.005B 0.00
Soligenix (SNGX) United States $0.005B 0.00
BioCardia (BCDA) United States $0.005B 0.00
Hepion Pharmaceuticals (HEPA) United States $0.005B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.005B 0.00
Bright Minds Biosciences (DRUG) United States $0.005B 0.00
Avalon GloboCare (ALBT) United States $0.005B 0.00
Hoth Therapeutics (HOTH) United States $0.005B 0.00
Adial Pharmaceuticals (ADIL) United States $0.004B 0.00
Artelo Biosciences (ARTL) United States $0.004B 0.00
Virios Therapeutics (VIRI) United States $0.004B 0.00
Exicure (XCUR) United States $0.004B 0.00
Trevena (TRVN) United States $0.004B 0.00
GENPREX (GNPX) United States $0.004B 0.00
Mustang Bio (MBIO) United States $0.004B 0.00
Palisade Bio (PALI) United States $0.004B 0.00
Tharimmune (THAR) United States $0.004B 0.00
GT Biopharma (GTBP) United States $0.004B 0.00
Enveric Biosciences (ENVB) United States $0.004B 0.00
Onconetix (ONCO) United States $0.003B 0.00
Portage Biotech (PRTG) $0.003B 0.00
Psyence Biomedical (PBM) United States $0.003B 0.00
Genetic Technologies (GENE) Australia $0.003B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.003B 0.00
Virpax Pharmaceuticals (VRPX) United States $0.003B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.003B 0.00
Atrinsic (PTIX) United States $0.003B 0.00
Ensysce Biosciences (ENSC) United States $0.003B 0.00
ARAVIVE, INC (ARAV) United States $0.003B 0.00
Invo BioScience (INVO) United States $0.003B 0.00
Allarity Therapeutics (ALLR) United States $0.003B 0.00
Alzamend Neuro (ALZN) United States $0.003B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.003B 0.00
Revelation Biosciences (REVB) United States $0.003B 0.00
Entero Therapeutics (ENTO) United States $0.003B 0.00
Cingulate (CING) United States $0.002B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.002B 0.00
180 Life Sciences (ATNF) United States $0.002B 0.00
Windtree Therapeutics (WINT) United States $0.002B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.002B 0.00
Aptevo Therapeutics (APVO) United States $0.002B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.002B 0.00
CNS Pharmaceuticals (CNSP) United States $0.002B 0.00
NeuBase Therapeutics (NBSE) United States $0.001B 0.00
Bone Biologics (BBLG) United States $0.001B 0.00
Seelos Therapeutics (SEEL) United States $0.001B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.001B 0.00
Dermata Therapeutics (DRMA) United States $0.001B 0.00
GRI Bio (GRI) United States $0.001B 0.00
Aceragen (ACGN) United States $0.000B 0.00
Alvotech (ALVO) $0.000B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
Mainz Biomed (MYNZ) Germany $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pharvaris (PHVS) Netherlands $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00